Abstracts

INFLAMMATORY GUT ILCs ASSOCIATE WITH DYSBIOSIS DURING UNTREATED HIV-1 INFECTION

HIV-1 infection is associated with a breakdown in intestinal homeostasis and changes in the enteric microbiota including increased abundances of pathobionts (e.g. Prevotella spp.). Normally, NKp44+ innate lymphoid cells (ILCs) within the mucosa maintain gut homeostasis through production of IL-22. ILCs also display functional plasticity and can produce inflammatory cytokines (e.g., IFNγ) in response to…

GUT-MICROBIOTA–RELATED METABOLIC PATHWAYS IN ELITE CONTROLLERS AND HIV PROGRESSORS

Gut microbiota dysbiosis features progressive HIV infection, with subsequent microbial translocation and systemic immune activation. Still, the microbial composition in gut of elite controllers (EC) has not been extensively explored, neither the corresponding metabolic pathways. 16 EC and 32 ART naïve progressors were recruited from a Swedish HIV cohort, and also 16 healthy controls (HC).…

CHANGES IN THE ORAL MICROBIOME WITH ART INITIATION

Changes in human oral microbiota have been linked to diseases of aging that are common in HIV, including atherosclerosis and certain cancers. Oral pathology, including thrush, oral hairy leukoplakia and periodontal disease, is common in chronic HIV infection. HIV has been associated with shifts in the microbiome at several sites, although no studies have longitudinally…

ACUTE HIV INFECTION AND HUMAN GUT MICROBIOME BEFORE AND AFTER ANTIRETROVIRAL THERAPY

The etiology of persistent immune activation in chronic HIV infection is incompletely understood and is probably multifactorial encompassing residual HIV replication, co-infections, mucosal alterations and deficient immune restoration. The intestinal gut microbiota could act as an integral driver of pathologic inflammation that persists even during the administration of antiretroviral therapy (ART). Anal swab samples were…

TWO-YEAR CART DOES NOT RESTORE PERIPHERAL BLOOD AND INTESTINAL HIV-RELATED DYSBIOSIS

Microbial dysbiosis features HIV+ individuals, both naïve and cART-treated, and is linked to anatomical/structural changes in the gastrointestinal (GI) tract, leading to microbial translocation (MT) and immune activation. Given that data on microbiota modifications during long-term therapy are lacking, we investigated gut/blood microbiota during the first 2 years of suppressive cART. We enrolled 41 HIV+,…

THE CHALLENGES OF TREATING MDR-TB IN CHILDREN

The paucibacillary nature of tuberculosis (TB) and the difficulty in obtaining samples for bacteriology in children are important barriers to diagnosis of paediatric MDR-TB. Although 25,000 children were estimated to have developed MDR-TB in 2014, only a small number are reported in the literature as appropriately treated from 1990-2014. Early and appropriate diagnosis is a…

VAGINAL MICROBIOME AND SUSCEPTIBILITY TO HIV

Several prospective studies published over nearly two decades have explored the relationship between vaginal dysbiosis and women’s risk of HIV acquisition. These studies have typically used Gram stain scoring based on bacterial morphotypes to characterize vaginal microbiota in categories including normal (scores 0-3), intermediate vaginal microbiota (scores 4-6), and bacterial vaginosis (BV; scores 7-10). Together,…